What is the SUPN stock price prediction for next 2 weeks?

According to our price prediction algorithm,Supernus Pharmaceuticals, Inc. (SUPN) price will be around $53.14 in the next 2 weeks. This means it will increase by 3.2261072261072297 from the last closing price. This prediction may vary from other time period filters for SUPN stock.

What can be the highest Possible price of SUPN stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, SUPN can achieve the highest price of $55.25 which is 7.322145025936319 higher than last closing price. This prediction may vary from other time period filters for SUPN stock.

What can be the lowest Possible price of SUPN stock in next 2 weeks?

As per the forecast and algorithmic analysis, SUPN stock price can be as low as $50.92 which is -1.089543911726542 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for SUPN stock.

Will SUPN stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that SUPN stock will gain3.2261072261072297 in the next 2 weeks. This prediction may vary from other time period filters for SUPN stock.

What is SUPN stock last closing price?

Last closing price of SUPN stock was $51.48.

What is SUPN stock price prediction?

SUPN stock price prediction means predicting the future closing prices of SUPN stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of SUPN stock in a certain time period.

How we predict SUPN stock future prices?

If you are searching for SUPN stock forecast, analysis or price prediction, then you might be wondering what Supernus Pharmaceuticals, Inc. (SUPN) will do in the future. Our SUPN price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This SUPN price prediction will likely answer most of your questions.

How frequent we update SUPN stock predictions?

We are updating the forecasts for the SUPN stock on daily basis.

Is using ML forecasting for SUPN stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for SUPN stock same for all the time periods?

No, the prediction for SUPN stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Supernus Pharmaceuticals, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$51.489.16%Since 2 Weeks

Predicted Price$53.143.23%For 2 Weeks

Upper Predicted Price$55.257.32%For 2 Weeks

Lower Predicted Price$50.92-1.09%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of SUPN will rise by +3.23% over the next 2 Weeks and hit $53.14 by Friday, January 2, 2026. In that time frame, SUPN's share price is expected to range between $50.92 and $55.25.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 2, 2026	51.05	53.14	55.40
Jan 1, 2026	50.52	52.72	54.84
Dec 31, 2025	50.98	52.86	55.08
Dec 30, 2025	51.98	53.91	55.87
Dec 29, 2025	51.35	53.35	55.43
Dec 26, 2025	50.46	52.31	54.17
Dec 25, 2025	50.12	51.89	53.84
Dec 24, 2025	49.99	52.03	53.86
Dec 23, 2025	51.26	53.08	54.96
Dec 22, 2025	50.66	52.52	54.28

SUPN shares fell -0.29% in Monday, December 22, 2025's trading session, dropping from a previous close of $51.48 to move at $51.33. The stock demonstrated notable intraday movement (see SUPN's key stats for a full breakdown), fluctuating between $50.61 and $51.66, a +2.08% trading range. While recent weeks have seen some volatility, SUPN has managed to secure a +12.37% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 1.62M shares changing hands, 1.12M more than the previous session. This amounted to $83.12M in total market activity.

Will SUPN Continue Its Upward Trend?

According to analyst ratings and projections for SUPN, Supernus Pharmaceuticals, Inc. shares are anticipated to increase by +7.35%, potentially reaching $55.40 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for SUPN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 19 positive trading days within the past 30 sessions. Based on the SUPN stock forecast, now is a good time to buy SUPN stock because its current trading price is -3.41% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on SUPN covering social and institutional perspectives.

SUPN Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into SUPN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 62.56% to 77.01%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 58.03%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 57.12%, maintains a neutral outlook for the long term. Insights into SUPN's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Supernus Pharmaceuticals Short-Term Forecasts

SUPN Forecast For Next 5 Days

Our algorithm anticipates Supernus Pharmaceuticals (SUPN) stock could hit $54.25 by Dec 29, 2025. This represents a +5.68% rise from today's price, following a +10.69% change over the past five days.

SUPN Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Supernus Pharmaceuticals, Inc. (SUPN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $50.77, which would mean a -1.09% decrease from the current price of $51.33. Projections for this period range from a high of $57.62 to a low of $45.55.

SUPN Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Supernus Pharmaceuticals's price over the next three months point to a rise. SUPN stock is expected to peak at $56.82 on Mar 18, 2026 after potentially dipping to $48.60 on Dec 23, 2025. On average, SUPN is likely to trade around $52.86 in the coming 90 days.

Supernus Pharmaceuticals Stock Forecast 2025

Based on our predictive models, Supernus Pharmaceuticals (SUPN) is expected to trade between $48.60 and $53.66 throughout 2025. This would result in an average price of $50.96, potentially offering investors a -0.72% return from current levels.

Supernus Pharmaceuticals, Inc. Monthly Forecast 2025–2026

December 2025

According to our latest forecast models, Supernus Pharmaceuticals, Inc. (SUPN) is positioned to show a strong performance in December 2025. The price is predicted to move between $48.60 and $53.66, settling at an average of $50.96. This could translate to a -0.72% loss.

January 2026

Based on current market signals, Supernus Pharmaceuticals, Inc. is projected to trend january 2026. We forecast a trading range from $49.08 to $55.04, with a likely average price of $52.40. Investors could expect a potential return of +2.08%.

February 2026

Our predictive algorithms indicate Supernus Pharmaceuticals, Inc. stock may see a shift in February 2026. The expected range spans $50.34–$56.15, with an average target of $53.26. This represents a positive outlook and a possible gain of +3.76%.

March 2026

Analyzing established trends, Supernus Pharmaceuticals, Inc. looks set to move in March 2026. Projections place the stock between $51.25 and $57.27, averaging around $54.22. This suggests a +5.63% gain from current levels.

April 2026

Market indicators suggest Supernus Pharmaceuticals, Inc. could experience notable changes during April 2026. Prices could fluctuate within $51.51 to $57.69, with a midpoint forecast of $54.43. The stock might deliver a +6.04% gain.

May 2026

Forecasting for May 2026, models estimate that Supernus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $49.74 and $57.05, averaging $53.23. This signals a positive trajectory with potential returns around +3.70%.

June 2026

According to our latest forecast models, Supernus Pharmaceuticals, Inc. (SUPN) is positioned to show a strong performance in June 2026. The price is predicted to move between $50.11 and $56.34, settling at an average of $53.36. This could translate to a +3.95% gain.

July 2026

Based on current market signals, Supernus Pharmaceuticals, Inc. is projected to trend july 2026. We forecast a trading range from $51.82 to $57.05, with a likely average price of $54.26. Investors could expect a potential return of +5.71%.

August 2026

Our predictive algorithms indicate Supernus Pharmaceuticals, Inc. stock may see a shift in August 2026. The expected range spans $52.14–$58.58, with an average target of $55.35. This represents a positive outlook and a possible gain of +7.83%.

September 2026

Analyzing established trends, Supernus Pharmaceuticals, Inc. looks set to move in September 2026. Projections place the stock between $52.32 and $58.12, averaging around $55.33. This suggests a +7.79% gain from current levels.

October 2026

Market indicators suggest Supernus Pharmaceuticals, Inc. could experience notable changes during October 2026. Prices could fluctuate within $50.33 to $58.06, with a midpoint forecast of $54.05. The stock might deliver a +5.30% gain.

November 2026

Forecasting for November 2026, models estimate that Supernus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $51.31 and $61.35, averaging $54.71. This signals a positive trajectory with potential returns around +6.58%.

December 2026

According to our latest forecast models, Supernus Pharmaceuticals, Inc. (SUPN) is positioned to show a strong performance in December 2026. The price is predicted to move between $52.72 and $57.58, settling at an average of $55.14. This could translate to a +7.42% gain.

SUPN's history of dividends and stock splits also plays a role in long-term investor confidence.